Trials / Conditions / Bone Marrow Failure

Bone Marrow Failure

18 registered clinical trials studyying Bone Marrow Failure — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The HOPE Biobank Resource (BMT CTN 2402 HOPE) NCT07227155	Medical College of Wisconsin	—
Recruiting	Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HS NCT06839456	Children's Hospital of Philadelphia	Phase 1 / Phase 2
Recruiting	European Rare Blood Disorders Platform (ENROL) NCT06250595	Hospital Universitari Vall d'Hebron Research Institute	—
Active Not Recruiting	Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure NCT04211714	Elixirgen Therapeutics, Inc.	Phase 1
Recruiting	Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders NCT04644016	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Ma NCT04232085	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2
Active Not Recruiting	Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant NCT03622788	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Recruiting	Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders NCT03579875	Masonic Cancer Center, University of Minnesota	Phase 2
Withdrawn	Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trau NCT03249129	University Hospital, Lille	—
Withdrawn	Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study NCT03086252	Emory University	N/A
Completed	NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia NCT02833805	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2
Unknown	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturn NCT01760096	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Unknown	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal H NCT01642979	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Completed	CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant NCT01049854	New York Medical College	Phase 2
Terminated	CD34+ Stem Cell Infusion to Augment Graft Function NCT01856582	Children's Hospital Medical Center, Cincinnati	Phase 2
Terminated	T-cell Depleted Alternative Donor Transplantation NCT00968864	Wake Forest University Health Sciences	Phase 2
Completed	Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Dis NCT01019876	Columbia University	Phase 2 / Phase 3
No Longer Available	Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Trans NCT01200017	Christopher Dvorak	—